Defensin Polypeptides Enhancing Antimicrobial Efficacy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current technologies lack effective solutions for producing polypeptides with antimicrobial activity that can efficiently kill or inhibit microbial growth, particularly against Escherichia coli and Bacillus subtilis, with varying concentrations and durations of effectiveness.
Innovation Solution
Development of defensin polypeptides with specific amino acid sequences, such as C-x(3)-C-x(7,9)-C-C-x(8)-C-x-C-x(8,11)-C, and corresponding nucleotides that encode these sequences, which are used to create recombinant expression vectors and host cells for production, enabling the production and use of these polypeptides with enhanced antimicrobial properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antimicrobial technologies are used, then microbial growth can be inhibited to some extent, but the effectiveness is insufficient and varies with concentration and duration
Solution Approach 1:
The patent modifies the amino acid sequence of defensin polypeptides by changing specific residues (e.g., position 1, 2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45) to enhance antimicrobial activity. These parameter changes in the molecular structure directly improve the reliability and productivity of microbial growth inhibition.
Solution Approach 2:
The patent introduces specific local modifications to the defensin polypeptide structure, such as adding N-terminal extensions with specific amino acid sequences (e.g., EE, DE, DD, EAE, EAQ, EAK) or modifying specific regions of the polypeptide. These localized quality changes enhance the overall antimicrobial effectiveness without requiring complete structural redesign.
2Productivity
If recombinant host cells are cultivated for polypeptide production, then large quantities of antimicrobial polypeptides can be produced, but production costs and process complexity increase
Solution Approach 1:
The patent divides the production system into separate functional components: the defensin polypeptide coding sequence, N-terminal extension sequences, promoter regions, and host cell systems. This segmentation allows for modular optimization of each component independently, reducing overall system complexity while maintaining high productivity.
Solution Approach 2:
The recombinant host cells are engineered to autonomously express and produce the modified defensin polypeptides when provided with the appropriate nucleic acid constructs. The system self-regulates through inherent cellular mechanisms for transcription, translation, and protein folding, reducing the need for complex external control systems.
Data Source
AI summary
The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using polypeptides.